Gena Wang, an analyst from Barclays, maintained the Hold rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price ...

Those around that level are, disproportionately, relatively small and risky companies whose prospects don't look all that ...

Evecxia Therapeutics?the first company dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification to treat central nervous system disorders?today announced the completion of ...

Vertex Pharmaceuticals Incorporated today provided updates on multiple kidney diseases in its pipeline including IgA ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

As we start looking to the year ahead, the pharma industry is gearing up for a slate of new drug launches and U.S. Food and ...

Interim Report BB Biotech: Strategic reallocation of portfolio assets progressing 25.10.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. BB Biotech: ...

On Thursday Oct. 24, 2024, Ark Invest, led by Cathie Wood, sold 85,456 Tesla shares valued at $22.22 million amid the stock's ...

The annual Santa Barbara Great Strides walk is a step around the corner and participating teams have already entered the race ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

On that note, let's dive in and investigate how the bull thesis for buying Vertex stock just got even stronger. Read More: ...